New Advances in the Treatment of Type 2 Diabetes: Clinical and Economic Implications for Managed Car
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Measles Outbreaks Cause Financial, Public Health Burden in US
4
Empagliflozin Reduces HF Risk After AMI in Patients With or Without Diabetes, CKD
5
